VALN Latest Headlines

Valneva’s Lyme Vaccine Catalysts Support Buy Rating and Significant Upside

at www.tipranks.com (Mon, 9-Nov 5:45 AM)

Valneva Announces November 24 Release of Nine-Month 2026 Results

at www.tipranks.com (Fri, 6-Nov 10:27 AM)

Pfizer and Valneva’s Lyme Disease Vaccine Passes Key European Regulatory Milestone—Efficacy Surpasses 70% in Phase 3 Trial

Market Chameleon (Fri, 14-Aug 7:05 AM)